KAMES FISH FARMING LIMITED

1. Executive Summary

Kames Fish Farming Limited occupies a highly differentiated niche as the UK's sole producer of Steelhead Trout, leveraging a vertically integrated supply chain from broodstock to harvest. However, the company is currently navigating severe financial and operational headwinds, evidenced by widening losses and a material going concern uncertainty tied to supplier credit. To secure its future, Kames must urgently stabilize its biological risk profile, renegotiate its capital structure, and capitalize on its premium product differentiation to offset global commodity pricing pressures.

2. Strategic Assets

• Product Differentiation & Monopoly Position: As the UK's exclusive producer of Steelhead Trout, Kames operates in a blue-ocean micro-market. This insulates them from direct domestic commodity competition and positions the product as a premium, niche alternative to traditional Atlantic salmon.
• Vertical Integration: The company controls the entire lifecycle—from hatching its own broodstock to producing 2-6 kg head-on gutted fish. This structural advantage provides supply chain resilience, traceability (increasingly demanded by retailers), and long-term margin optimization potential once operational disruptions are resolved.
• Top-Line Revenue Resilience: Despite significant biological disruptions and global price declines, turnover demonstrated strong organic growth, rising from £11.9M to £14.8M year-over-year. This indicates robust market demand and successful penetration into retail, wholesale, and international premium food service channels.

3. Growth Opportunities

• Broodstock Optimization: The strategic pivot to develop proprietary broodstock represents a high-value opportunity. By reducing reliance on external egg suppliers, Kames can drive genetic selection for disease resistance and growth efficiency, ultimately lowering unit costs and improving biological margins.
• International Premiumization: With existing inroads into the US, EU, and Asian markets, there is an actionable opportunity to shift volume toward international high-end food service channels that yield better margins than domestic wholesale, thereby offsetting global pricing volatility.
• Operational Turnaround: The current operating loss margin of (10.67%) is heavily skewed by the 2023 stock losses cascading into 2024. Merely returning to normalized biological operations (improving gill health and mitigating predator impacts) represents a massive embedded EBITDA uplift without requiring additional market share.

4. Strategic Risks

• Going Concern & Liquidity Crisis: The auditor's note regarding material uncertainty tied to key supplier credit is the most critical existential threat. If this credit facility is withdrawn, the company’s working capital position will immediately collapse. Strategic debt restructuring or external capital injection is imperative.
• Biological & Environmental Volatility: The 2023 stock losses clearly demonstrate the catastrophic impact of biological risks (gill health, sea lice) and environmental factors (seals, jellyfish). In aquaculture, margin destruction happens at the farm level; Kames must accelerate capital expenditure toward physical barriers (predator nets) and advanced health monitoring.
• Commodity Pricing Exposure: Increased global salmon and trout production suppressed sale prices in 2024, directly eroding profitability despite the volume increase. Kames remains structurally exposed to macroeconomic supply gluts, meaning its premium pricing strategy is not yet fully insulated against global commodity cycles.